Skip to content

Comparison of Exparel to Marcaine in Post-Surgical Analgesia in Bariatrics

Comparison of Exparel (Bupivacaine Liposome) to Marcaine (Bupivacaine) in Post-Surgical Analgesia for Laparoscopic Trocar Site Incisions in Bariatric Surgery

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02752230
Enrollment
0
Registered
2016-04-26
Start date
2016-11-29
Completion date
2021-06-01
Last updated
2020-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Keywords

Post operative pain, Bariatric Surgery

Brief summary

This study is designed to evaluate the use of bupivacaine liposome 1.3% compared bupivacaine 0.5% in pain control in post-operative laparoscopic bariatric surgery patient The purpose of this study is to evaluate two local anesthetics and determine if there is an advantage of administering one medication compared over the other. The intent is show that one local anesthetic.allows for improved pain control as per the pain scale ratings of the test subjects.

Interventions

Laparoscopic Roux en Y gastric bypass

PROCEDURELaparoscopic Sleeve Gastrectomy

Laparoscopic Sleeve Gastrectomy

Sponsors

Kettering Health Network
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

-Any patient scheduled to undergo Laparoscopic Roux en Y Gastric Bypass or Laparoscopic Gastric Sleeve with Dr. Stephen Fleischer

Exclusion criteria

* Patients with an allergy to either medications being studied any patient with neurological disorders that may be exacerbated by the use of either medication,including multiple sclerosis and amyotrophic lateral sclerosis or that may impact the perception of pain. * Patients with complex medical conditions that may confound data analysis per the principal investigator's discretion. * Any pregnant patient.Any patients that would not like to participate in the study. * Any patient that is not able to read or understand English

Design outcomes

Primary

MeasureTime frameDescription
Subjective Post Operative Pain LevelWithin the first 10 days after surgeryPost operative pain will be assessed on an subjective level. The patient's pain will be assessed by the use of the Wong-Baker pain scale.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026